Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Barry Uretsky

Concepts (614)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Percutaneous Coronary Intervention
97
2024
329
21.130
 Why?
Coronary Occlusion
58
2023
80
12.210
 Why?
Coronary Artery Disease
41
2024
324
11.780
 Why?
Fractional Flow Reserve, Myocardial
39
2023
127
10.990
 Why?
Angioplasty, Balloon, Coronary
48
2020
168
9.960
 Why?
Stents
50
2023
376
7.840
 Why?
Coronary Angiography
96
2023
369
7.610
 Why?
Coronary Vessels
33
2026
170
7.160
 Why?
Coronary Stenosis
22
2021
99
5.950
 Why?
Myocardial Infarction
46
2024
445
4.690
 Why?
Drug-Eluting Stents
22
2023
101
4.660
 Why?
Treatment Outcome
120
2024
5595
4.330
 Why?
Cardiac Catheterization
19
2023
229
3.680
 Why?
Coronary Artery Bypass
17
2022
134
2.750
 Why?
Acute Coronary Syndrome
8
2022
107
2.660
 Why?
Humans
229
2026
53230
2.490
 Why?
Chronic Disease
52
2023
580
2.260
 Why?
Tomography, Optical Coherence
8
2018
114
2.180
 Why?
Saphenous Vein
12
2021
63
2.040
 Why?
Graft Occlusion, Vascular
13
2021
81
1.990
 Why?
Platelet Aggregation Inhibitors
11
2014
213
1.910
 Why?
Risk Factors
65
2023
4017
1.910
 Why?
Myocardial Ischemia
12
2026
129
1.890
 Why?
Coronary Thrombosis
8
2020
22
1.830
 Why?
Registries
32
2023
652
1.630
 Why?
Thrombosis
11
2018
250
1.620
 Why?
Male
120
2024
27435
1.610
 Why?
Predictive Value of Tests
23
2023
934
1.600
 Why?
Cardiology
13
2019
106
1.590
 Why?
Coronary Restenosis
8
2021
39
1.590
 Why?
Myocardium
17
2013
471
1.500
 Why?
Heptanoic Acids
15
2008
35
1.450
 Why?
Aged
70
2023
10429
1.430
 Why?
Pyrroles
15
2008
73
1.410
 Why?
Time Factors
39
2023
2991
1.400
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
13
2022
146
1.350
 Why?
Heart Injuries
3
2019
16
1.280
 Why?
Middle Aged
78
2024
13419
1.270
 Why?
Risk Assessment
26
2023
1368
1.260
 Why?
Myocardial Reperfusion Injury
10
2011
53
1.150
 Why?
Cardiac Tamponade
2
2024
27
1.110
 Why?
Collateral Circulation
10
2020
39
1.070
 Why?
Female
80
2024
28782
1.050
 Why?
Vasodilator Agents
5
2016
90
0.990
 Why?
Coronary Circulation
9
2024
57
0.970
 Why?
Heart Failure
13
2019
531
0.950
 Why?
Heart-Assist Devices
3
2020
157
0.950
 Why?
Contrast Media
8
2018
178
0.910
 Why?
Prosthesis Design
11
2021
266
0.900
 Why?
Cardiac Catheters
4
2020
12
0.900
 Why?
Ventricular Dysfunction, Left
7
2018
107
0.900
 Why?
Societies, Medical
9
2019
207
0.890
 Why?
Thrombolytic Therapy
2
2020
114
0.890
 Why?
Pericarditis
2
2022
20
0.860
 Why?
Balloon Occlusion
1
2024
17
0.830
 Why?
Adenosine
7
2018
72
0.830
 Why?
Ventricular Function, Left
11
2023
178
0.820
 Why?
Pericardial Effusion
1
2024
40
0.810
 Why?
Coronary Disease
6
2015
144
0.800
 Why?
Hemorrhage
4
2019
226
0.800
 Why?
Cardiovascular Agents
5
2009
66
0.780
 Why?
Occupational Health
1
2023
64
0.770
 Why?
Aneurysm, False
5
2020
44
0.770
 Why?
Pericarditis, Constrictive
1
2022
2
0.760
 Why?
Postoperative Complications
10
2019
1099
0.760
 Why?
Aorta
3
2019
172
0.720
 Why?
Hypotension, Controlled
1
2021
3
0.710
 Why?
Radiography, Interventional
7
2018
58
0.710
 Why?
Anemia
1
2022
76
0.700
 Why?
Retrospective Studies
27
2020
6819
0.690
 Why?
Thrombocytopenia
1
2022
89
0.680
 Why?
Mammary Arteries
3
2017
10
0.680
 Why?
Absorbable Implants
2
2022
13
0.680
 Why?
Inferior Wall Myocardial Infarction
1
2020
1
0.660
 Why?
Thiazolidinediones
6
2008
81
0.650
 Why?
Time-to-Treatment
2
2020
81
0.630
 Why?
Shock, Cardiogenic
1
2020
35
0.630
 Why?
Algorithms
4
2021
667
0.630
 Why?
Prognosis
16
2023
2118
0.630
 Why?
Cardiovascular Diseases
11
2015
501
0.620
 Why?
Digitalis
1
2019
4
0.620
 Why?
Diabetic Angiopathies
2
2013
23
0.610
 Why?
Enbucrilate
1
2019
6
0.610
 Why?
Tissue Adhesives
1
2019
15
0.610
 Why?
Arterial Pressure
1
2019
44
0.610
 Why?
Hyperemia
3
2016
17
0.600
 Why?
Pericardium
4
2022
32
0.600
 Why?
Operative Time
3
2019
78
0.590
 Why?
Guideline Adherence
1
2020
143
0.590
 Why?
Practice Guidelines as Topic
2
2020
502
0.570
 Why?
Aspirin
5
2022
123
0.570
 Why?
Hematoma
2
2013
67
0.560
 Why?
Hydrostatic Pressure
1
2017
7
0.540
 Why?
Follow-Up Studies
16
2019
2318
0.540
 Why?
Myocardial Bridging
2
2026
3
0.530
 Why?
Angioplasty, Balloon
4
2022
69
0.530
 Why?
Death, Sudden, Cardiac
2
2008
55
0.530
 Why?
Perioperative Care
5
2015
44
0.520
 Why?
Heart Septum
2
2010
21
0.520
 Why?
Creatine Kinase, MB Form
3
2013
10
0.520
 Why?
Adrenergic beta-Antagonists
3
2008
108
0.520
 Why?
Surgical Procedures, Operative
4
2015
66
0.510
 Why?
Foramen Ovale, Patent
2
2014
32
0.500
 Why?
Purinergic P2Y Receptor Antagonists
2
2014
35
0.490
 Why?
Heart Ventricles
4
2012
260
0.490
 Why?
Veterans
1
2022
580
0.470
 Why?
Propranolol
2
2008
77
0.470
 Why?
Electrocardiography
10
2022
273
0.470
 Why?
United States
25
2022
5409
0.470
 Why?
Prospective Studies
14
2023
2411
0.470
 Why?
Severity of Illness Index
13
2019
1049
0.470
 Why?
Alloys
2
2020
10
0.460
 Why?
Fibrinolytic Agents
3
2014
132
0.440
 Why?
Aortic Valve
3
2022
130
0.440
 Why?
Tomography, X-Ray Computed
5
2013
1180
0.440
 Why?
Wounds, Penetrating
1
2015
39
0.440
 Why?
Vascular System Injuries
1
2015
42
0.430
 Why?
Randomized Controlled Trials as Topic
10
2015
630
0.430
 Why?
Ultrasonography, Interventional
7
2013
138
0.430
 Why?
Purines
2
2014
33
0.430
 Why?
Cardiotonic Agents
7
2019
70
0.420
 Why?
Adenosine A2 Receptor Agonists
1
2014
5
0.420
 Why?
Stroke Volume
7
2023
150
0.420
 Why?
Platelet Glycoprotein GPIIb-IIIa Complex
3
2009
46
0.420
 Why?
Physician-Patient Relations
1
2015
146
0.410
 Why?
Anterior Wall Myocardial Infarction
2
2012
7
0.410
 Why?
Computer-Assisted Instruction
1
2014
30
0.410
 Why?
Metals
2
2011
37
0.410
 Why?
Cyclooxygenase 2
8
2008
49
0.410
 Why?
Piperazines
2
2012
125
0.400
 Why?
Anticholesteremic Agents
3
2008
31
0.400
 Why?
Troponin T
2
2011
13
0.400
 Why?
Pyrazoles
2
2014
123
0.400
 Why?
Arteries
1
2013
93
0.400
 Why?
Mentors
1
2014
57
0.400
 Why?
Blood Vessel Prosthesis Implantation
4
2009
135
0.400
 Why?
Atrial Function, Left
1
2013
5
0.390
 Why?
Endarterectomy, Carotid
2
2011
63
0.390
 Why?
Lipoxins
3
2008
3
0.390
 Why?
Incidence
12
2018
1085
0.390
 Why?
Cardiac Surgical Procedures
3
2014
331
0.380
 Why?
Rats, Sprague-Dawley
14
2008
1544
0.380
 Why?
Tissue Donors
1
2013
130
0.380
 Why?
Rats
19
2011
3162
0.380
 Why?
Drug Eruptions
1
2012
14
0.380
 Why?
Physicians
2
2015
242
0.370
 Why?
Thiophenes
1
2012
45
0.370
 Why?
Stroke
3
2013
520
0.360
 Why?
Drug Administration Schedule
5
2014
370
0.360
 Why?
Quality Assurance, Health Care
4
2012
146
0.360
 Why?
Embolism
2
2013
18
0.360
 Why?
Cyclooxygenase Inhibitors
5
2007
40
0.360
 Why?
Angina Pectoris
3
2026
20
0.360
 Why?
Internet
1
2014
265
0.350
 Why?
Diverticulum
1
2011
21
0.350
 Why?
Troponin I
1
2011
19
0.340
 Why?
Transurethral Resection of Prostate
1
2011
10
0.340
 Why?
Intraoperative Complications
4
2020
114
0.340
 Why?
Carotid Arteries
1
2011
77
0.340
 Why?
Clinical Trials as Topic
4
2012
466
0.340
 Why?
Pressure
3
2017
102
0.340
 Why?
Receptors, Adrenergic, beta-2
2
2009
16
0.340
 Why?
Embolic Protection Devices
1
2010
7
0.330
 Why?
Myocytes, Cardiac
5
2011
147
0.330
 Why?
Receptors, Opioid, delta
2
2009
25
0.330
 Why?
Clinical Competence
4
2013
406
0.330
 Why?
Paclitaxel
1
2011
91
0.330
 Why?
Heart
5
2006
350
0.320
 Why?
Pericardiectomy
2
2024
6
0.320
 Why?
Mitral Valve
1
2010
57
0.320
 Why?
Endocarditis
1
2010
31
0.320
 Why?
Kaplan-Meier Estimate
6
2017
487
0.320
 Why?
Digoxin
3
2019
21
0.310
 Why?
Sirolimus
2
2009
72
0.300
 Why?
Echocardiography, Transesophageal
2
2006
63
0.300
 Why?
Anticoagulants
5
2024
280
0.290
 Why?
Carotid Artery, Common
2
2006
45
0.290
 Why?
Tissue Plasminogen Activator
1
2009
108
0.290
 Why?
Hypoglycemic Agents
3
2006
227
0.290
 Why?
Heart Failure, Systolic
1
2008
7
0.280
 Why?
Suction
1
2008
22
0.280
 Why?
Peptides
2
2008
234
0.280
 Why?
Azetidines
1
2008
7
0.280
 Why?
Heart Valve Prosthesis
2
2022
89
0.280
 Why?
Aortic Valve Stenosis
2
2022
79
0.280
 Why?
Consensus
2
2007
206
0.270
 Why?
Patient Selection
7
2012
273
0.270
 Why?
Animals
26
2026
13526
0.270
 Why?
Heart Septal Defects, Atrial
2
2013
45
0.270
 Why?
Telemedicine
1
2014
512
0.260
 Why?
Vascular Patency
5
2020
88
0.260
 Why?
Hemodynamics
7
2018
236
0.250
 Why?
Laboratories, Hospital
1
2006
6
0.250
 Why?
Defibrillators, Implantable
2
2007
62
0.250
 Why?
Coronary Aneurysm
1
2007
18
0.250
 Why?
Terminology as Topic
3
2013
72
0.250
 Why?
Chi-Square Distribution
3
2017
291
0.250
 Why?
Echocardiography, Three-Dimensional
1
2006
15
0.250
 Why?
Pacemaker, Artificial
1
2007
42
0.240
 Why?
Mitral Valve Insufficiency
2
2007
56
0.240
 Why?
Angina, Unstable
3
2016
25
0.240
 Why?
Bacteremia
1
2007
87
0.240
 Why?
Gadolinium DTPA
1
2005
26
0.230
 Why?
Inpatients
2
2018
208
0.230
 Why?
Nitric Oxide Synthase Type III
6
2008
83
0.230
 Why?
Kidney Failure, Chronic
2
2004
210
0.230
 Why?
Lipopolysaccharides
1
2006
203
0.230
 Why?
Carotid Artery Diseases
1
2005
33
0.230
 Why?
Calcium
1
2007
373
0.230
 Why?
Angina, Stable
2
2016
7
0.230
 Why?
Proportional Hazards Models
6
2017
445
0.230
 Why?
Prostaglandins
1
2005
21
0.220
 Why?
Neovascularization, Physiologic
2
2005
86
0.220
 Why?
Program Evaluation
1
2006
359
0.220
 Why?
Renal Insufficiency
1
2005
108
0.220
 Why?
Pain Management
3
2015
185
0.220
 Why?
Chemokine CCL2
1
2004
66
0.220
 Why?
Plasminogen Activator Inhibitor 1
1
2004
7
0.210
 Why?
Europe
6
2019
91
0.210
 Why?
History, 21st Century
2
2019
60
0.210
 Why?
Pericardiocentesis
1
2024
16
0.210
 Why?
Monocytes
1
2004
126
0.210
 Why?
History, 20th Century
2
2019
97
0.210
 Why?
Equipment Design
3
2020
290
0.210
 Why?
Staphylococcal Infections
1
2007
271
0.210
 Why?
Reoperation
5
2013
476
0.210
 Why?
Secondary Prevention
2
2015
85
0.210
 Why?
Reproducibility of Results
6
2016
1219
0.210
 Why?
Heart Rupture, Post-Infarction
1
2003
3
0.200
 Why?
Cardiomyopathy, Hypertrophic
1
2004
34
0.200
 Why?
Nitric Oxide Synthase Type II
4
2008
64
0.200
 Why?
Disease Models, Animal
9
2011
1517
0.200
 Why?
Double-Blind Method
5
2020
729
0.200
 Why?
Adult
14
2019
14534
0.190
 Why?
Materials Testing
2
2020
55
0.190
 Why?
Dose-Response Relationship, Drug
8
2017
1367
0.190
 Why?
Calcinosis
1
2023
53
0.190
 Why?
American Heart Association
4
2015
44
0.190
 Why?
Hospital Mortality
5
2019
457
0.190
 Why?
Femoral Artery
2
2019
106
0.180
 Why?
Coronary Vessel Anomalies
2
2017
37
0.180
 Why?
Recurrence
7
2016
694
0.180
 Why?
Angiography
3
2012
114
0.170
 Why?
Retreatment
2
2012
60
0.170
 Why?
Drug Therapy, Combination
5
2008
405
0.170
 Why?
Vasodilation
1
2021
100
0.170
 Why?
Up-Regulation
4
2011
456
0.170
 Why?
Heart Valve Prosthesis Implantation
2
2016
103
0.160
 Why?
United States Department of Veterans Affairs
1
2022
295
0.160
 Why?
Ischemia
1
2021
158
0.160
 Why?
Angioplasty
1
2020
21
0.160
 Why?
Calcitonin Gene-Related Peptide
2
2009
23
0.160
 Why?
Risk
3
2011
306
0.150
 Why?
6-Ketoprostaglandin F1 alpha
3
2008
4
0.150
 Why?
Plaque, Atherosclerotic
1
2019
45
0.150
 Why?
Logistic Models
3
2018
947
0.150
 Why?
Specialization
1
2019
48
0.150
 Why?
Atherectomy
1
2019
14
0.150
 Why?
Cost-Benefit Analysis
2
2014
274
0.150
 Why?
Russia
4
2019
10
0.150
 Why?
Propanolamines
2
2011
13
0.150
 Why?
Quality Improvement
2
2011
230
0.150
 Why?
Radial Artery
1
2019
34
0.150
 Why?
Catheterization
1
2019
95
0.150
 Why?
Survival Analysis
5
2010
659
0.140
 Why?
Odds Ratio
3
2016
567
0.140
 Why?
Catheterization, Peripheral
1
2019
49
0.140
 Why?
Peripheral Arterial Disease
1
2019
84
0.140
 Why?
Proto-Oncogene Proteins c-akt
3
2009
171
0.140
 Why?
Patient Care Planning
1
2019
69
0.140
 Why?
Feasibility Studies
1
2020
411
0.140
 Why?
Aged, 80 and over
5
2017
3494
0.140
 Why?
Patient Safety
1
2018
103
0.140
 Why?
Emergency Medical Services
1
2019
122
0.140
 Why?
Medicare
2
2011
280
0.130
 Why?
Education, Medical
1
2019
111
0.130
 Why?
Diabetes Mellitus, Type 2
1
2004
591
0.130
 Why?
Constriction, Pathologic
1
2017
91
0.130
 Why?
Adventitia
1
2017
3
0.130
 Why?
Education, Medical, Graduate
3
2013
219
0.130
 Why?
Curriculum
3
2013
409
0.130
 Why?
Hospitalization
3
2011
749
0.130
 Why?
Cardiac Pacing, Artificial
2
2008
32
0.130
 Why?
Advisory Committees
2
2014
75
0.130
 Why?
Prevalence
4
2018
1034
0.130
 Why?
Nitric Oxide Synthase
2
2008
64
0.120
 Why?
Phosphorylation
6
2008
533
0.120
 Why?
Simvastatin
2
2008
28
0.120
 Why?
Propensity Score
1
2017
170
0.120
 Why?
Aortic Valve Insufficiency
1
2016
25
0.120
 Why?
Administration, Oral
5
2015
456
0.120
 Why?
Benzazepines
2
2006
20
0.120
 Why?
Magnetic Resonance Imaging
1
2022
1583
0.110
 Why?
Renal Insufficiency, Chronic
1
2018
205
0.110
 Why?
Postpericardiotomy Syndrome
1
2015
4
0.110
 Why?
Diagnostic Techniques, Cardiovascular
2
2012
4
0.110
 Why?
Colchicine
1
2015
25
0.110
 Why?
Smad3 Protein
1
2014
9
0.110
 Why?
Cholesterol, Dietary
1
2014
19
0.110
 Why?
Th2 Cells
1
2014
20
0.110
 Why?
Cyclic AMP-Dependent Protein Kinases
3
2011
50
0.110
 Why?
Patient Care Management
1
2014
18
0.110
 Why?
Venous Thrombosis
1
2015
91
0.110
 Why?
Area Under Curve
3
2022
185
0.110
 Why?
Receptors, LDL
1
2014
73
0.110
 Why?
Health Care Costs
1
1995
178
0.110
 Why?
Cardiovascular System
1
2014
55
0.100
 Why?
Thromboembolism
1
2014
48
0.100
 Why?
Atherosclerosis
2
2014
224
0.100
 Why?
Transfection
1
2014
359
0.100
 Why?
Dependovirus
1
2014
104
0.100
 Why?
Drug Costs
1
2014
40
0.100
 Why?
Remote Consultation
1
2014
30
0.100
 Why?
Quality Indicators, Health Care
2
2011
92
0.100
 Why?
Arrhythmias, Cardiac
2
2012
98
0.100
 Why?
Cardiac Output, Low
2
2006
10
0.100
 Why?
Septal Occluder Device
1
2013
36
0.100
 Why?
Echocardiography, Doppler, Color
1
2013
21
0.100
 Why?
Pulmonary Edema
1
2013
15
0.100
 Why?
Echocardiography, Doppler
2
2016
56
0.100
 Why?
Cohort Studies
5
2022
1557
0.100
 Why?
General Surgery
1
2014
108
0.100
 Why?
Heparin
2
2024
86
0.100
 Why?
Evidence-Based Medicine
2
2011
275
0.100
 Why?
Pleural Effusion
1
2013
38
0.100
 Why?
Signal Transduction
3
2009
1748
0.090
 Why?
Case-Control Studies
2
2013
1212
0.090
 Why?
Image Processing, Computer-Assisted
1
2014
235
0.090
 Why?
Kidney Diseases
2
2007
230
0.090
 Why?
Embolism, Cholesterol
1
2011
2
0.090
 Why?
Multivariate Analysis
4
2016
598
0.090
 Why?
Heart Transplantation
3
2009
327
0.090
 Why?
Hypertrophy, Left Ventricular
2
2009
42
0.090
 Why?
Age Factors
3
2021
1136
0.090
 Why?
Myocardial Revascularization
2
2012
29
0.090
 Why?
Cardiovascular Surgical Procedures
2
2012
12
0.090
 Why?
Ultrasonography
2
2010
426
0.090
 Why?
Milrinone
1
2011
7
0.090
 Why?
Treatment Failure
2
2018
119
0.090
 Why?
Insurance Claim Review
1
2011
42
0.090
 Why?
Enkephalin, D-Penicillamine (2,5)-
2
2009
3
0.080
 Why?
Equipment Failure
2
2008
64
0.080
 Why?
Unnecessary Procedures
1
2011
20
0.080
 Why?
Punctures
2
2019
52
0.080
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
2011
73
0.080
 Why?
Thrombectomy
1
2011
74
0.080
 Why?
Necrosis
1
2010
169
0.080
 Why?
Cyclooxygenase 2 Inhibitors
2
2007
22
0.080
 Why?
Injections, Intra-Arterial
2
2015
14
0.080
 Why?
Disease Management
3
2014
187
0.080
 Why?
Cells, Cultured
4
2009
1569
0.080
 Why?
Surgical Instruments
1
2010
29
0.080
 Why?
Systole
1
2010
71
0.080
 Why?
Magnetic Resonance Imaging, Cine
1
2010
64
0.080
 Why?
Endothelium, Vascular
3
2007
262
0.080
 Why?
Receptors, Calcitonin Gene-Related Peptide
1
2009
4
0.080
 Why?
Reperfusion Injury
2
2007
82
0.080
 Why?
Phosphodiesterase Inhibitors
2
2007
21
0.080
 Why?
Myocardial Contraction
2
2009
109
0.070
 Why?
ROC Curve
2
2022
246
0.070
 Why?
Hyperlipidemias
2
2011
52
0.070
 Why?
Drug Administration Routes
1
2008
10
0.070
 Why?
Leukotriene B4
1
2008
1
0.070
 Why?
Arachidonate 5-Lipoxygenase
1
2008
3
0.070
 Why?
Fatal Outcome
2
2007
193
0.070
 Why?
Survival Rate
3
2018
949
0.070
 Why?
Hemostasis, Surgical
1
2008
11
0.070
 Why?
Phospholipases A
2
2006
14
0.070
 Why?
Phospholipases A2
2
2006
15
0.070
 Why?
Diabetes Complications
2
2011
124
0.070
 Why?
Patient Transfer
1
2009
99
0.070
 Why?
Comorbidity
1
2010
638
0.070
 Why?
Meta-Analysis as Topic
1
2008
40
0.070
 Why?
Drainage
1
2008
92
0.070
 Why?
Sulfonamides
2
2008
139
0.070
 Why?
Myocardial Reperfusion
1
2007
13
0.070
 Why?
Combined Modality Therapy
1
2009
640
0.070
 Why?
Mitogen-Activated Protein Kinase 3
1
2007
46
0.070
 Why?
Tetrazoles
1
2007
41
0.070
 Why?
Dipyridamole
1
2007
7
0.070
 Why?
Prosthesis Failure
2
2012
113
0.070
 Why?
Microinjections
2
2018
34
0.070
 Why?
Prostaglandin D2
1
2007
21
0.070
 Why?
Cyclooxygenase 1
1
2007
7
0.060
 Why?
Waiting Lists
1
2007
56
0.060
 Why?
Analysis of Variance
1
2008
547
0.060
 Why?
Sex Factors
2
2022
747
0.060
 Why?
Disease Progression
2
2008
880
0.060
 Why?
Calcium Signaling
1
2007
52
0.060
 Why?
Nitroso Compounds
1
2006
3
0.060
 Why?
Patient Admission
1
2007
81
0.060
 Why?
Thoracic Surgery
1
2007
22
0.060
 Why?
Enzyme Induction
1
2006
75
0.060
 Why?
PPAR gamma
1
2007
74
0.060
 Why?
Biotin
1
2006
46
0.060
 Why?
Chest Pain
1
2006
55
0.060
 Why?
NF-kappa B
1
2008
327
0.060
 Why?
Ubiquinone
1
2006
14
0.060
 Why?
Drug Interactions
1
2007
196
0.060
 Why?
Acute Disease
3
2019
393
0.060
 Why?
Hemofiltration
1
2006
8
0.060
 Why?
Magnesium
1
2006
33
0.060
 Why?
Diagnosis, Differential
2
2012
1038
0.060
 Why?
Electric Countershock
1
2006
30
0.060
 Why?
Forecasting
1
2007
152
0.060
 Why?
Preoperative Care
1
2007
173
0.060
 Why?
Intracranial Embolism
1
2006
29
0.060
 Why?
Radiology
1
2008
137
0.060
 Why?
Heart Atria
1
2006
64
0.060
 Why?
Ischemic Preconditioning
1
2005
5
0.060
 Why?
Texas
2
2006
138
0.060
 Why?
Aortic Rupture
1
2006
19
0.060
 Why?
Triiodobenzoic Acids
1
2005
9
0.060
 Why?
Partnership Practice
1
2005
1
0.060
 Why?
Organizational Affiliation
1
2005
2
0.060
 Why?
Myocardial Stunning
1
2005
2
0.060
 Why?
Health Planning
1
2005
13
0.060
 Why?
Carbazoles
1
2005
17
0.060
 Why?
Pyrrolidines
1
2006
65
0.060
 Why?
Foreign Bodies
1
2006
66
0.060
 Why?
Metoprolol
1
2005
13
0.060
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2006
124
0.060
 Why?
Gastrointestinal Hemorrhage
1
2006
91
0.060
 Why?
Device Removal
1
2006
89
0.060
 Why?
Aortic Coarctation
1
2006
32
0.060
 Why?
Accidents, Traffic
1
2006
91
0.060
 Why?
Arginine Vasopressin
1
2005
6
0.060
 Why?
Isoxazoles
1
2005
16
0.060
 Why?
Intramolecular Oxidoreductases
1
2005
11
0.060
 Why?
Prostaglandin-Endoperoxide Synthases
1
2005
25
0.060
 Why?
Tetralogy of Fallot
1
2006
83
0.060
 Why?
Education, Medical, Continuing
1
2005
76
0.060
 Why?
Ephedrine
1
2004
21
0.050
 Why?
Regional Blood Flow
1
2004
112
0.050
 Why?
Leadership
1
2005
106
0.050
 Why?
Hyperhomocysteinemia
1
2004
29
0.050
 Why?
Membrane Proteins
1
2007
333
0.050
 Why?
Polyethylene Terephthalates
1
2004
10
0.050
 Why?
Brachiocephalic Trunk
1
2004
6
0.050
 Why?
Abnormalities, Multiple
1
2006
166
0.050
 Why?
Ventricular Remodeling
1
2004
66
0.050
 Why?
Pregnancy Complications, Cardiovascular
1
2004
31
0.050
 Why?
Antioxidants
1
2006
264
0.050
 Why?
Creatinine
1
2004
158
0.050
 Why?
Vascular Endothelial Growth Factor A
1
2005
189
0.050
 Why?
Arteriosclerosis
1
2004
49
0.050
 Why?
Random Allocation
1
2005
284
0.050
 Why?
Swine Diseases
1
2004
7
0.050
 Why?
Hypertension
2
2011
554
0.050
 Why?
Potassium Channels
1
2004
32
0.050
 Why?
ATP-Binding Cassette Transporters
1
2004
35
0.050
 Why?
Enoxaparin
1
2024
32
0.050
 Why?
Inflammation
2
2007
652
0.050
 Why?
Cytochrome P-450 Enzyme System
1
2005
191
0.050
 Why?
Staphylococcus aureus
1
2007
313
0.050
 Why?
Vasoconstrictor Agents
1
2004
81
0.050
 Why?
Atrial Fibrillation
1
2006
197
0.050
 Why?
Heart Diseases
1
2006
221
0.050
 Why?
Glomerular Filtration Rate
2
2018
128
0.050
 Why?
Creatine Kinase
1
2003
31
0.050
 Why?
Sample Size
1
2003
50
0.050
 Why?
Isoenzymes
1
2003
165
0.050
 Why?
Retroperitoneal Space
1
2002
26
0.050
 Why?
Health Policy
2
2012
165
0.050
 Why?
Internship and Residency
1
2008
439
0.050
 Why?
Death
1
2022
23
0.050
 Why?
C-Reactive Protein
1
2003
152
0.050
 Why?
Quality of Life
1
2008
902
0.050
 Why?
Immunohistochemistry
1
2005
975
0.050
 Why?
Cardiomyopathies
1
2003
120
0.050
 Why?
Drug Synergism
3
2007
147
0.050
 Why?
Morphine Derivatives
1
2022
28
0.040
 Why?
Anesthesia
1
2002
67
0.040
 Why?
Renal Dialysis
1
2003
196
0.040
 Why?
Epoprostenol
1
2001
12
0.040
 Why?
Mass Screening
1
2004
362
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2001
48
0.040
 Why?
Hospitals
1
2022
181
0.040
 Why?
Pulmonary Wedge Pressure
1
2001
18
0.040
 Why?
Benchmarking
2
2011
64
0.040
 Why?
Kidney
1
2005
715
0.040
 Why?
Heart Arrest
1
2002
144
0.040
 Why?
Tissue Scaffolds
1
2020
40
0.040
 Why?
Arkansas
2
2016
2068
0.040
 Why?
Biocompatible Materials
1
2020
67
0.040
 Why?
Public Policy
2
2012
39
0.040
 Why?
Antihypertensive Agents
1
2001
130
0.040
 Why?
Anti-Inflammatory Agents
2
2015
164
0.040
 Why?
Graft Rejection
2
2009
166
0.040
 Why?
Oxidative Stress
1
2004
819
0.040
 Why?
Risk Adjustment
1
2019
17
0.040
 Why?
Mice, Knockout
2
2014
910
0.040
 Why?
Injections, Intralesional
1
2018
32
0.040
 Why?
Internationality
1
2018
46
0.040
 Why?
Radiation Dosage
1
2019
160
0.040
 Why?
Administration, Intravenous
1
2018
73
0.030
 Why?
Immunoblotting
2
2008
118
0.030
 Why?
Sex Characteristics
1
1999
204
0.030
 Why?
Radiation Monitoring
1
2017
7
0.030
 Why?
International Cooperation
2
2007
52
0.030
 Why?
Enzyme-Linked Immunosorbent Assay
2
2008
233
0.030
 Why?
Interferon-alpha
1
1996
53
0.030
 Why?
Mice
3
2014
5982
0.030
 Why?
Italy
1
2015
27
0.030
 Why?
Blood Flow Velocity
1
2015
99
0.030
 Why?
Phlebography
1
2015
55
0.030
 Why?
Cost Savings
1
1995
60
0.030
 Why?
Tubulin Modulators
1
2015
28
0.030
 Why?
Monte Carlo Method
1
1995
89
0.030
 Why?
Decision Support Techniques
1
1995
73
0.030
 Why?
Cross-Sectional Studies
1
2020
1723
0.030
 Why?
Cause of Death
2
2007
156
0.030
 Why?
Syndrome
2
2006
248
0.030
 Why?
Time
1
2014
28
0.030
 Why?
Journal Impact Factor
1
2014
9
0.030
 Why?
Liver Transplantation
1
1996
174
0.030
 Why?
Genetic Vectors
1
2014
127
0.030
 Why?
Models, Cardiovascular
2
2004
22
0.030
 Why?
Fibrosis
1
2014
198
0.030
 Why?
Monitoring, Physiologic
1
2014
122
0.030
 Why?
Learning Curve
1
2013
20
0.020
 Why?
Apoptosis
2
2011
1139
0.020
 Why?
Ischemic Attack, Transient
1
2013
59
0.020
 Why?
Cardiac Imaging Techniques
1
2012
8
0.020
 Why?
Gene Expression Regulation
2
2008
1003
0.020
 Why?
Mice, Inbred C57BL
2
2008
1925
0.020
 Why?
Tissue Survival
1
2012
10
0.020
 Why?
Myocardial Perfusion Imaging
1
2012
17
0.020
 Why?
Exercise Test
2
2002
137
0.020
 Why?
Tomography, Emission-Computed, Single-Photon
1
2012
53
0.020
 Why?
Phosphodiesterase 3 Inhibitors
1
2011
1
0.020
 Why?
Adrenergic beta-1 Receptor Antagonists
1
2011
7
0.020
 Why?
In Situ Nick-End Labeling
1
2011
54
0.020
 Why?
Echocardiography
2
2005
409
0.020
 Why?
Diagnostic Imaging
1
2012
176
0.020
 Why?
Recovery of Function
1
2012
203
0.020
 Why?
Infusions, Intravenous
1
2011
211
0.020
 Why?
Critical Care
1
2012
215
0.020
 Why?
Lymphocytes
1
1991
146
0.020
 Why?
Program Development
1
2011
165
0.020
 Why?
Data Collection
1
2011
288
0.020
 Why?
Adrenergic beta-2 Receptor Antagonists
1
2009
1
0.020
 Why?
Adrenergic beta-2 Receptor Agonists
1
2009
5
0.020
 Why?
Transplantation, Homologous
1
2009
154
0.020
 Why?
Cell Death
1
2009
171
0.020
 Why?
Isoquinolines
1
2008
22
0.020
 Why?
Serine
1
2008
36
0.020
 Why?
Tyrphostins
1
2008
10
0.020
 Why?
Janus Kinases
1
2008
7
0.020
 Why?
Electrophoretic Mobility Shift Assay
1
2008
71
0.020
 Why?
Selection Bias
1
2008
15
0.020
 Why?
Enzyme Activation
1
2008
267
0.020
 Why?
Ischemic Preconditioning, Myocardial
1
2007
4
0.020
 Why?
Organ Culture Techniques
1
2007
44
0.020
 Why?
Creatine Kinase, BB Form
1
2007
1
0.020
 Why?
Immunologic Factors
1
2008
117
0.020
 Why?
Receptors, Purinergic P1
1
2007
7
0.020
 Why?
Survival
1
2007
12
0.020
 Why?
Theophylline
1
2007
18
0.020
 Why?
5'-Nucleotidase
1
2007
12
0.020
 Why?
Nitriles
1
2007
55
0.020
 Why?
Blood Coagulation
1
2007
65
0.020
 Why?
Smoking
1
2011
526
0.020
 Why?
Models, Chemical
1
2007
65
0.020
 Why?
Premedication
1
2007
17
0.020
 Why?
Butadienes
1
2007
49
0.020
 Why?
Drug Combinations
1
2007
138
0.020
 Why?
Coenzymes
1
2006
3
0.020
 Why?
Fluid Therapy
1
2007
79
0.020
 Why?
Oncogene Protein v-akt
1
2006
12
0.020
 Why?
Receptors, Vasopressin
1
2006
23
0.020
 Why?
Alanine
1
2006
43
0.020
 Why?
Phosphoric Monoester Hydrolases
1
2006
25
0.020
 Why?
Educational Measurement
1
2008
202
0.020
 Why?
Amidines
1
2006
6
0.020
 Why?
Benzylamines
1
2006
14
0.020
 Why?
Sulfones
1
2006
24
0.010
 Why?
Protein Kinase Inhibitors
1
2008
233
0.010
 Why?
PTEN Phosphohydrolase
1
2006
55
0.010
 Why?
Research Design
1
2008
373
0.010
 Why?
Models, Animal
1
2006
233
0.010
 Why?
Nitric Oxide
1
2007
233
0.010
 Why?
Magnetic Resonance Angiography
1
2006
72
0.010
 Why?
Heart Conduction System
1
2005
25
0.010
 Why?
Body Weight
1
2007
524
0.010
 Why?
Safety
1
2005
78
0.010
 Why?
Enzyme Inhibitors
1
2007
371
0.010
 Why?
Nitroglycerin
1
2004
6
0.010
 Why?
Multicenter Studies as Topic
1
2005
114
0.010
 Why?
Radiography
1
2006
476
0.010
 Why?
Injections, Intravenous
1
2004
129
0.010
 Why?
Aortography
1
2004
33
0.010
 Why?
Sensitivity and Specificity
1
2006
867
0.010
 Why?
Glyburide
1
2004
5
0.010
 Why?
Anastomosis, Surgical
1
2004
69
0.010
 Why?
Anesthesia, Obstetrical
1
2004
40
0.010
 Why?
Ventricular Fibrillation
1
2004
19
0.010
 Why?
Health Personnel
1
2007
259
0.010
 Why?
Models, Biological
1
2007
737
0.010
 Why?
Vascular Surgical Procedures
1
2006
171
0.010
 Why?
Statistics as Topic
1
2004
89
0.010
 Why?
Patient Discharge
1
2006
325
0.010
 Why?
Transcription Factors
1
2007
571
0.010
 Why?
Tachycardia, Ventricular
1
2004
44
0.010
 Why?
Anti-Arrhythmia Agents
1
2004
79
0.010
 Why?
Cesarean Section
1
2004
158
0.010
 Why?
NG-Nitroarginine Methyl Ester
1
2003
11
0.010
 Why?
Swine
1
2004
440
0.010
 Why?
Endpoint Determination
1
2002
27
0.010
 Why?
Brain
1
2006
1350
0.010
 Why?
Pregnancy
1
2004
2608
0.010
 Why?
Hepatitis C
1
1996
82
0.010
 Why?
HLA Antigens
1
1992
55
0.010
 Why?
Immunity, Cellular
1
1991
64
0.010
 Why?
Uretsky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (614) concept(s)
_
Co-Authors Expand Description
See all (10) people
_
Similar People Expand Description
See all (23) people
_
Same Department Expand Description
Search Department